Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Of The Efficacy Of Tazarotene 0.045% Versus Halobetasol Propionate 0.01% Lotion For the Treatment of Scalp Psoriasis

NCT06015152 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.

NCT NCT06015152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06015152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Of The Efficacy Of Tazarotene 0.045% Versus Halobetasol Propionate 0.01% Lotion For the Treatment of Scalp Psoriasis
Lead sponsor
Jinnah Postgraduate Medical Centre
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2022
Completion date
February 1, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scalp psoriasis